Chenghui Pharma to Showcase Pharmaceutical Innovations at CPHI China 2025 (Booth W1A30)

Chenghui Shuangda


CPHI China 2025: Shandong Chenghui Pharmaceutical Group to Showcase Innovations at Booth W1A30

The global pharmaceutical industry's premier event, CPHI China International Pharmaceutical Ingredients Exhibition, will open its doors in Shanghai from June 24-26, 2025. Shandong Chenghui Pharmaceutical Group cordially invites you to visit Booth W1A30 to explore cutting-edge innovations and technical services.



About Chenghui

Rooted in Shandong Province, Chenghui Pharmaceutical Group upholds the core values of "integrity-first, open collaboration, and innovation-driven," specializing in pharmaceutical ingredients, advanced intermediates, MAH, CDMO, veterinary medicine, and health products.

Established in 2014, its subsidiary Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. is a $500 million international production base focusing on high-end APIs and intermediates. The 200-acre facility in Dezhou Plain Economic Development Zone features:


6 GMP-compliant production workshops with 10 production lines

cGMP-standard R&D platforms and quality control centers

Annual capacity exceeding 1,000 tons, meeting international certification requirements.



Exhibition Highlights (Booth W1A30)

✅ Innovation Showcase
Featured areas: local anesthetics, oncology, cardiovascular, antiviral, and gastrointestinal therapeutics, presenting novel APIs, green synthesis technologies, and customized CDMO solutions.

✅ Expert Consultation
Technical specialists and business representatives will provide one-on-one support for process optimization and regulatory compliance.

✅ Industry Insights
Engage in concurrent events to discuss pharmaceutical trends with Chenghui's team.




Event Details



Date: June 24-26, 2025

Venue: Shanghai New International Expo Centre

Booth: W1A30 (Core zone of Hall W1).



Exhibition Scope



Pharmaceutical Ingredients & Intermediates

Chemical APIs: Vitamins, hormones, analgesics, cardiovascular drugs (20+ categories)

Specialty: Cephalosporins, macrolides, and amino acid derivatives.

Biopharmaceuticals & Technologies

Biologics: Antibody drugs, cell therapies, nucleic acid drugs, and vaccines

International Zone: W1-W4 halls feature global biotech innovations.

Support Services & Equipment

CDMO/CRO services covering process development to mass production

Packaging equipment and lab instruments (linked with PMEC China exhibits).



Collaborate for Innovation

As a pivotal platform for industry exchange, Chenghui looks forward to connecting at Booth W1A30 to co-create opportunities in global healthcare.

June 24-26, 2025 | Shanghai New International Expo Centre | See you there!


Previous:
Next:

Copyright 2018 Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. All Rights Reserved Lu ICP 18055647